nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—ABCG2—Omeprazole—Barrett's esophagus	0.142	0.209	CbGbCtD
Gefitinib—CYP1A1—Omeprazole—Barrett's esophagus	0.131	0.193	CbGbCtD
Gefitinib—CYP2C19—Esomeprazole—Barrett's esophagus	0.108	0.159	CbGbCtD
Gefitinib—CYP2C19—Omeprazole—Barrett's esophagus	0.0634	0.0935	CbGbCtD
Gefitinib—CYP2C9—Omeprazole—Barrett's esophagus	0.0527	0.0777	CbGbCtD
Gefitinib—CYP3A4—Esomeprazole—Barrett's esophagus	0.052	0.0767	CbGbCtD
Gefitinib—ABCB1—Omeprazole—Barrett's esophagus	0.0512	0.0754	CbGbCtD
Gefitinib—CYP2D6—Omeprazole—Barrett's esophagus	0.0482	0.0711	CbGbCtD
Gefitinib—CYP3A4—Omeprazole—Barrett's esophagus	0.0307	0.0452	CbGbCtD
Gefitinib—ORM1—bile—Barrett's esophagus	0.0126	0.251	CbGeAlD
Gefitinib—ERBB3—exocrine gland—Barrett's esophagus	0.00743	0.148	CbGeAlD
Gefitinib—Erlotinib—NR1I2—Barrett's esophagus	0.00491	1	CrCbGaD
Gefitinib—Rectal disorder—Esomeprazole—Barrett's esophagus	0.00471	0.0267	CcSEcCtD
Gefitinib—Rectal disorder—Omeprazole—Barrett's esophagus	0.00471	0.0267	CcSEcCtD
Gefitinib—Anorectal disorder—Esomeprazole—Barrett's esophagus	0.00439	0.0249	CcSEcCtD
Gefitinib—Anorectal disorder—Omeprazole—Barrett's esophagus	0.00439	0.0249	CcSEcCtD
Gefitinib—Eruption—Omeprazole—Barrett's esophagus	0.00375	0.0213	CcSEcCtD
Gefitinib—Eruption—Esomeprazole—Barrett's esophagus	0.00375	0.0213	CcSEcCtD
Gefitinib—Hypomagnesaemia—Omeprazole—Barrett's esophagus	0.00364	0.0206	CcSEcCtD
Gefitinib—Hypomagnesaemia—Esomeprazole—Barrett's esophagus	0.00364	0.0206	CcSEcCtD
Gefitinib—ERBB3—epithelium—Barrett's esophagus	0.00323	0.0644	CbGeAlD
Gefitinib—MKNK2—epithelium—Barrett's esophagus	0.00308	0.0612	CbGeAlD
Gefitinib—MKNK2—smooth muscle tissue—Barrett's esophagus	0.00296	0.059	CbGeAlD
Gefitinib—IRAK1—smooth muscle tissue—Barrett's esophagus	0.00296	0.059	CbGeAlD
Gefitinib—Proteinuria—Esomeprazole—Barrett's esophagus	0.00263	0.0149	CcSEcCtD
Gefitinib—Proteinuria—Omeprazole—Barrett's esophagus	0.00263	0.0149	CcSEcCtD
Gefitinib—Protein urine present—Omeprazole—Barrett's esophagus	0.00259	0.0147	CcSEcCtD
Gefitinib—Protein urine present—Esomeprazole—Barrett's esophagus	0.00259	0.0147	CcSEcCtD
Gefitinib—CSNK1E—digestive system—Barrett's esophagus	0.00255	0.0507	CbGeAlD
Gefitinib—ERBB3—digestive system—Barrett's esophagus	0.00246	0.049	CbGeAlD
Gefitinib—MKNK2—digestive system—Barrett's esophagus	0.00234	0.0466	CbGeAlD
Gefitinib—MKNK1—digestive system—Barrett's esophagus	0.00231	0.046	CbGeAlD
Gefitinib—Cystitis noninfective—Esomeprazole—Barrett's esophagus	0.00226	0.0128	CcSEcCtD
Gefitinib—Melaena—Omeprazole—Barrett's esophagus	0.00226	0.0128	CcSEcCtD
Gefitinib—Melaena—Esomeprazole—Barrett's esophagus	0.00226	0.0128	CcSEcCtD
Gefitinib—Cystitis noninfective—Omeprazole—Barrett's esophagus	0.00226	0.0128	CcSEcCtD
Gefitinib—Cystitis—Esomeprazole—Barrett's esophagus	0.00223	0.0126	CcSEcCtD
Gefitinib—Cystitis—Omeprazole—Barrett's esophagus	0.00223	0.0126	CcSEcCtD
Gefitinib—Dry eye—Esomeprazole—Barrett's esophagus	0.00213	0.0121	CcSEcCtD
Gefitinib—Dry eye—Omeprazole—Barrett's esophagus	0.00213	0.0121	CcSEcCtD
Gefitinib—Bladder pain—Omeprazole—Barrett's esophagus	0.00209	0.0118	CcSEcCtD
Gefitinib—Mouth ulceration—Omeprazole—Barrett's esophagus	0.00209	0.0118	CcSEcCtD
Gefitinib—Bladder pain—Esomeprazole—Barrett's esophagus	0.00209	0.0118	CcSEcCtD
Gefitinib—Mouth ulceration—Esomeprazole—Barrett's esophagus	0.00209	0.0118	CcSEcCtD
Gefitinib—STK10—digestive system—Barrett's esophagus	0.0019	0.0379	CbGeAlD
Gefitinib—Hepatic failure—Omeprazole—Barrett's esophagus	0.00187	0.0106	CcSEcCtD
Gefitinib—Hepatic failure—Esomeprazole—Barrett's esophagus	0.00187	0.0106	CcSEcCtD
Gefitinib—Dry skin—Omeprazole—Barrett's esophagus	0.00154	0.0087	CcSEcCtD
Gefitinib—Dry skin—Esomeprazole—Barrett's esophagus	0.00154	0.0087	CcSEcCtD
Gefitinib—Hypokalaemia—Omeprazole—Barrett's esophagus	0.00153	0.00864	CcSEcCtD
Gefitinib—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.00153	0.00864	CcSEcCtD
Gefitinib—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.00151	0.00855	CcSEcCtD
Gefitinib—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00151	0.00855	CcSEcCtD
Gefitinib—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.00151	0.00855	CcSEcCtD
Gefitinib—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.00151	0.00855	CcSEcCtD
Gefitinib—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.00148	0.00837	CcSEcCtD
Gefitinib—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00148	0.00837	CcSEcCtD
Gefitinib—Pancreatitis—Esomeprazole—Barrett's esophagus	0.00142	0.00804	CcSEcCtD
Gefitinib—Pancreatitis—Omeprazole—Barrett's esophagus	0.00142	0.00804	CcSEcCtD
Gefitinib—Weight decreased—Esomeprazole—Barrett's esophagus	0.00131	0.00742	CcSEcCtD
Gefitinib—Weight decreased—Omeprazole—Barrett's esophagus	0.00131	0.00742	CcSEcCtD
Gefitinib—Infestation—Esomeprazole—Barrett's esophagus	0.00129	0.00732	CcSEcCtD
Gefitinib—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00129	0.00732	CcSEcCtD
Gefitinib—Infestation—Omeprazole—Barrett's esophagus	0.00129	0.00732	CcSEcCtD
Gefitinib—Infestation NOS—Omeprazole—Barrett's esophagus	0.00129	0.00732	CcSEcCtD
Gefitinib—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.00128	0.00725	CcSEcCtD
Gefitinib—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.00128	0.00725	CcSEcCtD
Gefitinib—Stomatitis—Omeprazole—Barrett's esophagus	0.00126	0.00713	CcSEcCtD
Gefitinib—Stomatitis—Esomeprazole—Barrett's esophagus	0.00126	0.00713	CcSEcCtD
Gefitinib—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.00126	0.00711	CcSEcCtD
Gefitinib—Conjunctivitis—Omeprazole—Barrett's esophagus	0.00126	0.00711	CcSEcCtD
Gefitinib—Haematuria—Omeprazole—Barrett's esophagus	0.00123	0.00698	CcSEcCtD
Gefitinib—Haematuria—Esomeprazole—Barrett's esophagus	0.00123	0.00698	CcSEcCtD
Gefitinib—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00122	0.00692	CcSEcCtD
Gefitinib—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00122	0.00692	CcSEcCtD
Gefitinib—Epistaxis—Omeprazole—Barrett's esophagus	0.00122	0.0069	CcSEcCtD
Gefitinib—Epistaxis—Esomeprazole—Barrett's esophagus	0.00122	0.0069	CcSEcCtD
Gefitinib—Hepatitis—Esomeprazole—Barrett's esophagus	0.00116	0.00657	CcSEcCtD
Gefitinib—Hepatitis—Omeprazole—Barrett's esophagus	0.00116	0.00657	CcSEcCtD
Gefitinib—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.00115	0.00649	CcSEcCtD
Gefitinib—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.00115	0.00649	CcSEcCtD
Gefitinib—Oedema peripheral—Omeprazole—Barrett's esophagus	0.00114	0.00647	CcSEcCtD
Gefitinib—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.00114	0.00647	CcSEcCtD
Gefitinib—Urethral disorder—Omeprazole—Barrett's esophagus	0.00114	0.00644	CcSEcCtD
Gefitinib—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00114	0.00644	CcSEcCtD
Gefitinib—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.0011	0.00621	CcSEcCtD
Gefitinib—Erythema multiforme—Omeprazole—Barrett's esophagus	0.0011	0.00621	CcSEcCtD
Gefitinib—Eye disorder—Esomeprazole—Barrett's esophagus	0.00108	0.00614	CcSEcCtD
Gefitinib—Eye disorder—Omeprazole—Barrett's esophagus	0.00108	0.00614	CcSEcCtD
Gefitinib—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00105	0.00592	CcSEcCtD
Gefitinib—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00105	0.00592	CcSEcCtD
Gefitinib—CYP1A1—epithelium—Barrett's esophagus	0.00103	0.0205	CbGeAlD
Gefitinib—Alopecia—Esomeprazole—Barrett's esophagus	0.00102	0.0058	CcSEcCtD
Gefitinib—Alopecia—Omeprazole—Barrett's esophagus	0.00102	0.0058	CcSEcCtD
Gefitinib—Malnutrition—Omeprazole—Barrett's esophagus	0.00101	0.00572	CcSEcCtD
Gefitinib—Malnutrition—Esomeprazole—Barrett's esophagus	0.00101	0.00572	CcSEcCtD
Gefitinib—CYP2C19—digestive system—Barrett's esophagus	0.000974	0.0194	CbGeAlD
Gefitinib—Anaemia—Omeprazole—Barrett's esophagus	0.000933	0.00528	CcSEcCtD
Gefitinib—Anaemia—Esomeprazole—Barrett's esophagus	0.000933	0.00528	CcSEcCtD
Gefitinib—Angioedema—Omeprazole—Barrett's esophagus	0.000922	0.00522	CcSEcCtD
Gefitinib—Angioedema—Esomeprazole—Barrett's esophagus	0.000922	0.00522	CcSEcCtD
Gefitinib—Malaise—Esomeprazole—Barrett's esophagus	0.00091	0.00516	CcSEcCtD
Gefitinib—Malaise—Omeprazole—Barrett's esophagus	0.00091	0.00516	CcSEcCtD
Gefitinib—Cough—Omeprazole—Barrett's esophagus	0.000881	0.00499	CcSEcCtD
Gefitinib—Cough—Esomeprazole—Barrett's esophagus	0.000881	0.00499	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000853	0.00483	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000853	0.00483	CcSEcCtD
Gefitinib—Dry mouth—Esomeprazole—Barrett's esophagus	0.000841	0.00476	CcSEcCtD
Gefitinib—Dry mouth—Omeprazole—Barrett's esophagus	0.000841	0.00476	CcSEcCtD
Gefitinib—Infection—Esomeprazole—Barrett's esophagus	0.000818	0.00464	CcSEcCtD
Gefitinib—Infection—Omeprazole—Barrett's esophagus	0.000818	0.00464	CcSEcCtD
Gefitinib—Shock—Esomeprazole—Barrett's esophagus	0.000811	0.00459	CcSEcCtD
Gefitinib—Shock—Omeprazole—Barrett's esophagus	0.000811	0.00459	CcSEcCtD
Gefitinib—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000808	0.00458	CcSEcCtD
Gefitinib—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000808	0.00458	CcSEcCtD
Gefitinib—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000807	0.00457	CcSEcCtD
Gefitinib—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000807	0.00457	CcSEcCtD
Gefitinib—Skin disorder—Esomeprazole—Barrett's esophagus	0.0008	0.00453	CcSEcCtD
Gefitinib—Skin disorder—Omeprazole—Barrett's esophagus	0.0008	0.00453	CcSEcCtD
Gefitinib—Anorexia—Omeprazole—Barrett's esophagus	0.000785	0.00445	CcSEcCtD
Gefitinib—Anorexia—Esomeprazole—Barrett's esophagus	0.000785	0.00445	CcSEcCtD
Gefitinib—CYP1A1—digestive system—Barrett's esophagus	0.000785	0.0156	CbGeAlD
Gefitinib—CYP3A5—digestive system—Barrett's esophagus	0.000767	0.0153	CbGeAlD
Gefitinib—CYP2C9—digestive system—Barrett's esophagus	0.000755	0.015	CbGeAlD
Gefitinib—Dyspnoea—Omeprazole—Barrett's esophagus	0.000735	0.00416	CcSEcCtD
Gefitinib—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000735	0.00416	CcSEcCtD
Gefitinib—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000716	0.00406	CcSEcCtD
Gefitinib—Decreased appetite—Omeprazole—Barrett's esophagus	0.000716	0.00406	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000711	0.00403	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000711	0.00403	CcSEcCtD
Gefitinib—Fatigue—Esomeprazole—Barrett's esophagus	0.00071	0.00402	CcSEcCtD
Gefitinib—Fatigue—Omeprazole—Barrett's esophagus	0.00071	0.00402	CcSEcCtD
Gefitinib—Pain—Esomeprazole—Barrett's esophagus	0.000705	0.00399	CcSEcCtD
Gefitinib—Constipation—Esomeprazole—Barrett's esophagus	0.000705	0.00399	CcSEcCtD
Gefitinib—Pain—Omeprazole—Barrett's esophagus	0.000705	0.00399	CcSEcCtD
Gefitinib—Constipation—Omeprazole—Barrett's esophagus	0.000705	0.00399	CcSEcCtD
Gefitinib—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000674	0.00382	CcSEcCtD
Gefitinib—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000674	0.00382	CcSEcCtD
Gefitinib—Urticaria—Esomeprazole—Barrett's esophagus	0.000654	0.00371	CcSEcCtD
Gefitinib—Urticaria—Omeprazole—Barrett's esophagus	0.000654	0.00371	CcSEcCtD
Gefitinib—Body temperature increased—Omeprazole—Barrett's esophagus	0.000651	0.00369	CcSEcCtD
Gefitinib—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000651	0.00369	CcSEcCtD
Gefitinib—Abdominal pain—Omeprazole—Barrett's esophagus	0.000651	0.00369	CcSEcCtD
Gefitinib—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000651	0.00369	CcSEcCtD
Gefitinib—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000607	0.00344	CcSEcCtD
Gefitinib—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000607	0.00344	CcSEcCtD
Gefitinib—Asthenia—Esomeprazole—Barrett's esophagus	0.000591	0.00335	CcSEcCtD
Gefitinib—Asthenia—Omeprazole—Barrett's esophagus	0.000591	0.00335	CcSEcCtD
Gefitinib—Pruritus—Omeprazole—Barrett's esophagus	0.000583	0.0033	CcSEcCtD
Gefitinib—Pruritus—Esomeprazole—Barrett's esophagus	0.000583	0.0033	CcSEcCtD
Gefitinib—CYP3A4—digestive system—Barrett's esophagus	0.000576	0.0115	CbGeAlD
Gefitinib—CYP2D6—digestive system—Barrett's esophagus	0.000567	0.0113	CbGeAlD
Gefitinib—Diarrhoea—Omeprazole—Barrett's esophagus	0.000564	0.00319	CcSEcCtD
Gefitinib—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000564	0.00319	CcSEcCtD
Gefitinib—ABCB1—epithelium—Barrett's esophagus	0.000536	0.0107	CbGeAlD
Gefitinib—Vomiting—Omeprazole—Barrett's esophagus	0.000524	0.00297	CcSEcCtD
Gefitinib—Vomiting—Esomeprazole—Barrett's esophagus	0.000524	0.00297	CcSEcCtD
Gefitinib—Rash—Omeprazole—Barrett's esophagus	0.000519	0.00294	CcSEcCtD
Gefitinib—Rash—Esomeprazole—Barrett's esophagus	0.000519	0.00294	CcSEcCtD
Gefitinib—Dermatitis—Esomeprazole—Barrett's esophagus	0.000519	0.00294	CcSEcCtD
Gefitinib—Dermatitis—Omeprazole—Barrett's esophagus	0.000519	0.00294	CcSEcCtD
Gefitinib—Nausea—Omeprazole—Barrett's esophagus	0.000489	0.00277	CcSEcCtD
Gefitinib—Nausea—Esomeprazole—Barrett's esophagus	0.000489	0.00277	CcSEcCtD
Gefitinib—ABCB1—digestive system—Barrett's esophagus	0.000408	0.00811	CbGeAlD
Gefitinib—ERBB3—ErbB Signaling Pathway—TP53—Barrett's esophagus	0.000228	0.00254	CbGpPWpGaD
Gefitinib—IRAK1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RELA—Barrett's esophagus	0.000226	0.00252	CbGpPWpGaD
Gefitinib—IRAK1—Apoptosis Modulation and Signaling—CDKN2A—Barrett's esophagus	0.000225	0.00251	CbGpPWpGaD
Gefitinib—CSNK1E—Circadian rythm related genes—PPARG—Barrett's esophagus	0.000223	0.00249	CbGpPWpGaD
Gefitinib—IRAK1—MyD88 dependent cascade initiated on endosome—RELA—Barrett's esophagus	0.000222	0.00248	CbGpPWpGaD
Gefitinib—IRAK4—Regulation of toll-like receptor signaling pathway—CXCL8—Barrett's esophagus	0.000219	0.00244	CbGpPWpGaD
Gefitinib—CYP3A5—Biological oxidations—CYP26A1—Barrett's esophagus	0.000218	0.00243	CbGpPWpGaD
Gefitinib—CSNK1E—TCF dependent signaling in response to WNT—APC—Barrett's esophagus	0.000217	0.00242	CbGpPWpGaD
Gefitinib—CYP3A5—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000215	0.0024	CbGpPWpGaD
Gefitinib—IRAK1—Toll Like Receptor 9 (TLR9) Cascade—RELA—Barrett's esophagus	0.000214	0.00239	CbGpPWpGaD
Gefitinib—CHEK2—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000214	0.00238	CbGpPWpGaD
Gefitinib—IRAK1—MyD88:Mal cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.000211	0.00235	CbGpPWpGaD
Gefitinib—CSNK1E—RNF mutants show enhanced WNT signaling and proliferation—APC—Barrett's esophagus	0.00021	0.00234	CbGpPWpGaD
Gefitinib—CHEK2—Cell Cycle—TP53—Barrett's esophagus	0.00021	0.00234	CbGpPWpGaD
Gefitinib—CYP1A1—Biological oxidations—CYP26A1—Barrett's esophagus	0.000206	0.0023	CbGpPWpGaD
Gefitinib—CYP1A1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000203	0.00227	CbGpPWpGaD
Gefitinib—IRAK1—MyD88-independent cascade—RELA—Barrett's esophagus	0.000202	0.00225	CbGpPWpGaD
Gefitinib—LOC400927-CSNK1E—Circadian rythm related genes—TP53—Barrett's esophagus	0.000199	0.00222	CbGpPWpGaD
Gefitinib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000198	0.00221	CbGpPWpGaD
Gefitinib—EGFR—Bladder Cancer—TP53—Barrett's esophagus	0.000198	0.00221	CbGpPWpGaD
Gefitinib—EGFR—Gastric Cancer Network 2—TP53—Barrett's esophagus	0.000198	0.00221	CbGpPWpGaD
Gefitinib—IRAK1—Toll-like Receptor Signaling Pathway—RELA—Barrett's esophagus	0.000197	0.0022	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling by WNT in cancer—APC—Barrett's esophagus	0.000195	0.00217	CbGpPWpGaD
Gefitinib—EGFR—LPA receptor mediated events—RELA—Barrett's esophagus	0.000192	0.00214	CbGpPWpGaD
Gefitinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000191	0.00213	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by Interleukins—RELA—Barrett's esophagus	0.000189	0.0021	CbGpPWpGaD
Gefitinib—CHEK2—Cell Cycle Checkpoints—TP53—Barrett's esophagus	0.000188	0.0021	CbGpPWpGaD
Gefitinib—EGFR—AGE/RAGE pathway—RELA—Barrett's esophagus	0.000187	0.00209	CbGpPWpGaD
Gefitinib—MAP2K5—BDNF signaling pathway—RELA—Barrett's esophagus	0.000187	0.00208	CbGpPWpGaD
Gefitinib—IRAK1—Toll-like Receptor Signaling Pathway—CXCL8—Barrett's esophagus	0.000186	0.00207	CbGpPWpGaD
Gefitinib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000185	0.00206	CbGpPWpGaD
Gefitinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—RELA—Barrett's esophagus	0.000185	0.00206	CbGpPWpGaD
Gefitinib—IRAK1—Activated TLR4 signalling—RELA—Barrett's esophagus	0.000182	0.00203	CbGpPWpGaD
Gefitinib—EGFR—LPA receptor mediated events—CXCL8—Barrett's esophagus	0.000181	0.00201	CbGpPWpGaD
Gefitinib—CSNK1E—Wnt Signaling Pathway and Pluripotency—TP53—Barrett's esophagus	0.00018	0.00201	CbGpPWpGaD
Gefitinib—EGFR—Direct p53 effectors—HGF—Barrett's esophagus	0.000177	0.00197	CbGpPWpGaD
Gefitinib—ABCG2—Fluoropyrimidine Activity—TP53—Barrett's esophagus	0.000176	0.00196	CbGpPWpGaD
Gefitinib—IRAK1—Toll Like Receptor 4 (TLR4) Cascade—RELA—Barrett's esophagus	0.000171	0.00191	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	0.000169	0.00189	CbGpPWpGaD
Gefitinib—CYP2C19—Biological oxidations—CYP26A1—Barrett's esophagus	0.000169	0.00188	CbGpPWpGaD
Gefitinib—CYP2C19—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000166	0.00186	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways in Glioblastoma—CDKN2A—Barrett's esophagus	0.000163	0.00182	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	0.000163	0.00182	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling by Wnt—APC—Barrett's esophagus	0.000161	0.00179	CbGpPWpGaD
Gefitinib—ERBB3—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.00016	0.00178	CbGpPWpGaD
Gefitinib—ALB—Platelet degranulation—HGF—Barrett's esophagus	0.000159	0.00177	CbGpPWpGaD
Gefitinib—CYP1A1—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000158	0.00176	CbGpPWpGaD
Gefitinib—IRAK1—p75(NTR)-mediated signaling—TP53—Barrett's esophagus	0.000156	0.00174	CbGpPWpGaD
Gefitinib—MKNK1—MAPK Signaling Pathway—TP53—Barrett's esophagus	0.000155	0.00173	CbGpPWpGaD
Gefitinib—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000155	0.00173	CbGpPWpGaD
Gefitinib—IRAK1—Regulation of toll-like receptor signaling pathway—RELA—Barrett's esophagus	0.000154	0.00172	CbGpPWpGaD
Gefitinib—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	0.000154	0.00172	CbGpPWpGaD
Gefitinib—CHEK2—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	0.000153	0.00171	CbGpPWpGaD
Gefitinib—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.000153	0.00171	CbGpPWpGaD
Gefitinib—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000153	0.00171	CbGpPWpGaD
Gefitinib—ERBB3—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000153	0.0017	CbGpPWpGaD
Gefitinib—IRAK1—Toll-Like Receptors Cascades—RELA—Barrett's esophagus	0.000152	0.0017	CbGpPWpGaD
Gefitinib—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000152	0.00169	CbGpPWpGaD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—HGF—Barrett's esophagus	0.000152	0.00169	CbGpPWpGaD
Gefitinib—ALB—Response to elevated platelet cytosolic Ca2+—HGF—Barrett's esophagus	0.000152	0.00169	CbGpPWpGaD
Gefitinib—EGFR—Androgen receptor signaling pathway—RELA—Barrett's esophagus	0.000147	0.00164	CbGpPWpGaD
Gefitinib—MKNK1—Disease—SLC9A1—Barrett's esophagus	0.000146	0.00162	CbGpPWpGaD
Gefitinib—IRAK1—Regulation of toll-like receptor signaling pathway—CXCL8—Barrett's esophagus	0.000145	0.00162	CbGpPWpGaD
Gefitinib—CYP1A1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000143	0.0016	CbGpPWpGaD
Gefitinib—ERBB3—B Cell Activation—RELA—Barrett's esophagus	0.000141	0.00157	CbGpPWpGaD
Gefitinib—EGFR—Focal Adhesion—HGF—Barrett's esophagus	0.000138	0.00154	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—GAST—Barrett's esophagus	0.000133	0.00148	CbGpPWpGaD
Gefitinib—IRAK4—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	0.000133	0.00148	CbGpPWpGaD
Gefitinib—ALB—Vitamin B12 Metabolism—RELA—Barrett's esophagus	0.000132	0.00148	CbGpPWpGaD
Gefitinib—EGFR—Direct p53 effectors—APC—Barrett's esophagus	0.000131	0.00146	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000131	0.00146	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—PPARG—Barrett's esophagus	0.000129	0.00144	CbGpPWpGaD
Gefitinib—CHEK2—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000127	0.00142	CbGpPWpGaD
Gefitinib—EGFR—ErbB Signaling Pathway—TP53—Barrett's esophagus	0.000127	0.00142	CbGpPWpGaD
Gefitinib—IRAK1—Apoptosis Modulation and Signaling—TP53—Barrett's esophagus	0.000125	0.00139	CbGpPWpGaD
Gefitinib—EGFR—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000125	0.00139	CbGpPWpGaD
Gefitinib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000122	0.00136	CbGpPWpGaD
Gefitinib—CYP2C19—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000117	0.00131	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—PTGS2—Barrett's esophagus	0.000114	0.00127	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—SLC9A1—Barrett's esophagus	0.000113	0.00126	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—CXCL8—Barrett's esophagus	0.000111	0.00123	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling by NGF—RELA—Barrett's esophagus	0.000108	0.0012	CbGpPWpGaD
Gefitinib—ALB—Folate Metabolism—RELA—Barrett's esophagus	0.000108	0.0012	CbGpPWpGaD
Gefitinib—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000107	0.00119	CbGpPWpGaD
Gefitinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—TP53—Barrett's esophagus	0.000107	0.00119	CbGpPWpGaD
Gefitinib—CSNK1E—Circadian rythm related genes—TP53—Barrett's esophagus	0.000105	0.00117	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000104	0.00116	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—RELA—Barrett's esophagus	0.000104	0.00116	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by NGF—RELA—Barrett's esophagus	0.000104	0.00116	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—GAST—Barrett's esophagus	0.000103	0.00115	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000102	0.00114	CbGpPWpGaD
Gefitinib—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000101	0.00113	CbGpPWpGaD
Gefitinib—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.0001	0.00112	CbGpPWpGaD
Gefitinib—CHEK2—Cell Cycle—CDKN2A—Barrett's esophagus	9.89e-05	0.0011	CbGpPWpGaD
Gefitinib—ALB—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	9.73e-05	0.00109	CbGpPWpGaD
Gefitinib—CYP1A1—PPARA activates gene expression—PPARG—Barrett's esophagus	9.7e-05	0.00108	CbGpPWpGaD
Gefitinib—MAP2K5—MAPK Signaling Pathway—TP53—Barrett's esophagus	9.54e-05	0.00106	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	9.52e-05	0.00106	CbGpPWpGaD
Gefitinib—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Barrett's esophagus	9.49e-05	0.00106	CbGpPWpGaD
Gefitinib—CSNK1E—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	9.48e-05	0.00106	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—SST—Barrett's esophagus	9.11e-05	0.00102	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	9.09e-05	0.00101	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	8.9e-05	0.000992	CbGpPWpGaD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	8.8e-05	0.000981	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by NGF—RELA—Barrett's esophagus	8.65e-05	0.000965	CbGpPWpGaD
Gefitinib—ERBB3—Disease—SLC9A1—Barrett's esophagus	8.62e-05	0.000962	CbGpPWpGaD
Gefitinib—ALB—Selenium Micronutrient Network—RELA—Barrett's esophagus	8.56e-05	0.000954	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	8.55e-05	0.000953	CbGpPWpGaD
Gefitinib—EGFR—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	8.49e-05	0.000947	CbGpPWpGaD
Gefitinib—CSNK1E—Cell Cycle—CDKN2A—Barrett's esophagus	8.47e-05	0.000945	CbGpPWpGaD
Gefitinib—ALB—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	8.31e-05	0.000927	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—GAST—Barrett's esophagus	8.17e-05	0.000911	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	8.07e-05	0.0009	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	8.01e-05	0.000894	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—GAST—Barrett's esophagus	7.88e-05	0.000878	CbGpPWpGaD
Gefitinib—EGFR—B Cell Activation—RELA—Barrett's esophagus	7.86e-05	0.000876	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.79e-05	0.000869	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	7.76e-05	0.000866	CbGpPWpGaD
Gefitinib—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	7.7e-05	0.000859	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—HGF—Barrett's esophagus	7.46e-05	0.000832	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—RELA—Barrett's esophagus	7.43e-05	0.000829	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—GAST—Barrett's esophagus	7.42e-05	0.000828	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—SST—Barrett's esophagus	7.09e-05	0.00079	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	7.07e-05	0.000788	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	7.06e-05	0.000787	CbGpPWpGaD
Gefitinib—MKNK1—Disease—APC—Barrett's esophagus	6.88e-05	0.000768	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PTGES—Barrett's esophagus	6.87e-05	0.000766	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—TP53—Barrett's esophagus	6.79e-05	0.000758	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—GAST—Barrett's esophagus	6.56e-05	0.000731	CbGpPWpGaD
Gefitinib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	6.54e-05	0.000729	CbGpPWpGaD
Gefitinib—ALB—Folate Metabolism—TP53—Barrett's esophagus	6.23e-05	0.000695	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—HGF—Barrett's esophagus	5.95e-05	0.000664	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—RELA—Barrett's esophagus	5.93e-05	0.000661	CbGpPWpGaD
Gefitinib—EGFR—Direct p53 effectors—TP53—Barrett's esophagus	5.92e-05	0.000661	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—RELA—Barrett's esophagus	5.78e-05	0.000645	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—RELA—Barrett's esophagus	5.69e-05	0.000635	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—SST—Barrett's esophagus	5.6e-05	0.000625	CbGpPWpGaD
Gefitinib—EGFR—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	5.58e-05	0.000622	CbGpPWpGaD
Gefitinib—CHEK2—Cell Cycle—TP53—Barrett's esophagus	5.5e-05	0.000614	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—SST—Barrett's esophagus	5.4e-05	0.000602	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—APC—Barrett's esophagus	5.35e-05	0.000597	CbGpPWpGaD
Gefitinib—MKNK1—Disease—PTGS2—Barrett's esophagus	5.23e-05	0.000583	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—CYP26A1—Barrett's esophagus	5.21e-05	0.000581	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	5.16e-05	0.000576	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—TP53—Barrett's esophagus	5.12e-05	0.000571	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—SST—Barrett's esophagus	5.09e-05	0.000567	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—HGF—Barrett's esophagus	4.95e-05	0.000552	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	4.95e-05	0.000552	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—RELA—Barrett's esophagus	4.93e-05	0.00055	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PTGES—Barrett's esophagus	4.92e-05	0.000549	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—APC—Barrett's esophagus	4.82e-05	0.000538	CbGpPWpGaD
Gefitinib—EGFR—Disease—SLC9A1—Barrett's esophagus	4.8e-05	0.000535	CbGpPWpGaD
Gefitinib—CSNK1E—Cell Cycle—TP53—Barrett's esophagus	4.72e-05	0.000526	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PTGES—Barrett's esophagus	4.65e-05	0.000519	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	4.62e-05	0.000515	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—PPARG—Barrett's esophagus	4.61e-05	0.000515	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—SST—Barrett's esophagus	4.49e-05	0.000501	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—GAST—Barrett's esophagus	4.39e-05	0.000489	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	4.33e-05	0.000483	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—RELA—Barrett's esophagus	4.33e-05	0.000483	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PTGES—Barrett's esophagus	4.24e-05	0.000473	CbGpPWpGaD
Gefitinib—ERBB3—Disease—APC—Barrett's esophagus	4.08e-05	0.000455	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—PTGS2—Barrett's esophagus	4.06e-05	0.000453	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	3.92e-05	0.000437	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PTGES—Barrett's esophagus	3.81e-05	0.000424	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—RELA—Barrett's esophagus	3.77e-05	0.00042	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—SLC9A1—Barrett's esophagus	3.75e-05	0.000419	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—APC—Barrett's esophagus	3.75e-05	0.000418	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—RELA—Barrett's esophagus	3.74e-05	0.000417	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	3.73e-05	0.000416	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PTGES—Barrett's esophagus	3.71e-05	0.000414	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—HGF—Barrett's esophagus	3.64e-05	0.000406	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—CXCL8—Barrett's esophagus	3.55e-05	0.000396	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CYP26A1—Barrett's esophagus	3.52e-05	0.000393	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PTGES—Barrett's esophagus	3.5e-05	0.00039	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PTGES—Barrett's esophagus	3.47e-05	0.000387	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—RELA—Barrett's esophagus	3.45e-05	0.000385	CbGpPWpGaD
Gefitinib—EGFR—Immune System—HGF—Barrett's esophagus	3.31e-05	0.000369	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—RELA—Barrett's esophagus	3.3e-05	0.000368	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CYP26A1—Barrett's esophagus	3.21e-05	0.000358	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—RELA—Barrett's esophagus	3.17e-05	0.000353	CbGpPWpGaD
Gefitinib—ERBB3—Disease—PTGS2—Barrett's esophagus	3.1e-05	0.000345	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—SST—Barrett's esophagus	3.01e-05	0.000335	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—APC—Barrett's esophagus	2.96e-05	0.00033	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—RELA—Barrett's esophagus	2.93e-05	0.000327	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	2.88e-05	0.000322	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—RELA—Barrett's esophagus	2.87e-05	0.000321	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—APC—Barrett's esophagus	2.86e-05	0.000319	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	2.82e-05	0.000314	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CXCL8—Barrett's esophagus	2.76e-05	0.000308	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	2.69e-05	0.0003	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	2.65e-05	0.000296	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	2.63e-05	0.000293	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.6e-05	0.00029	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—SLC9A1—Barrett's esophagus	2.54e-05	0.000283	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—APC—Barrett's esophagus	2.38e-05	0.000265	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.37e-05	0.000265	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	2.33e-05	0.00026	CbGpPWpGaD
Gefitinib—ALB—Metabolism—SLC9A1—Barrett's esophagus	2.32e-05	0.000258	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—RELA—Barrett's esophagus	2.32e-05	0.000258	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PTGES—Barrett's esophagus	2.29e-05	0.000255	CbGpPWpGaD
Gefitinib—EGFR—Disease—APC—Barrett's esophagus	2.27e-05	0.000253	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—RELA—Barrett's esophagus	2.23e-05	0.000249	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CXCL8—Barrett's esophagus	2.18e-05	0.000243	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TP53—Barrett's esophagus	2.18e-05	0.000243	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.13e-05	0.000238	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CXCL8—Barrett's esophagus	2.1e-05	0.000235	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	2.08e-05	0.000232	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.05e-05	0.000228	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	2.03e-05	0.000226	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CXCL8—Barrett's esophagus	1.98e-05	0.000221	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.94e-05	0.000217	CbGpPWpGaD
Gefitinib—EGFR—Immune System—RELA—Barrett's esophagus	1.92e-05	0.000214	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	1.91e-05	0.000213	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	1.9e-05	0.000211	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.87e-05	0.000208	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—RELA—Barrett's esophagus	1.86e-05	0.000207	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CXCL8—Barrett's esophagus	1.75e-05	0.000195	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.73e-05	0.000193	CbGpPWpGaD
Gefitinib—EGFR—Disease—PTGS2—Barrett's esophagus	1.72e-05	0.000192	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PPARG—Barrett's esophagus	1.71e-05	0.000191	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TP53—Barrett's esophagus	1.69e-05	0.000189	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.68e-05	0.000187	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—APC—Barrett's esophagus	1.59e-05	0.000177	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.53e-05	0.00017	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PTGS2—Barrett's esophagus	1.35e-05	0.00015	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TP53—Barrett's esophagus	1.34e-05	0.000149	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TP53—Barrett's esophagus	1.29e-05	0.000144	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.25e-05	0.000139	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—RELA—Barrett's esophagus	1.24e-05	0.000139	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PPARG—Barrett's esophagus	1.23e-05	0.000137	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—TP53—Barrett's esophagus	1.22e-05	0.000136	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CXCL8—Barrett's esophagus	1.17e-05	0.000131	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PPARG—Barrett's esophagus	1.16e-05	0.000129	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TP53—Barrett's esophagus	1.07e-05	0.00012	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PPARG—Barrett's esophagus	1.06e-05	0.000118	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	9.66e-06	0.000108	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PPARG—Barrett's esophagus	9.49e-06	0.000106	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PPARG—Barrett's esophagus	9.26e-06	0.000103	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PTGS2—Barrett's esophagus	9.12e-06	0.000102	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PPARG—Barrett's esophagus	8.73e-06	9.74e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PPARG—Barrett's esophagus	8.65e-06	9.65e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PTGS2—Barrett's esophagus	8.32e-06	9.28e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	7.47e-06	8.33e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PTGS2—Barrett's esophagus	7.29e-06	8.13e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TP53—Barrett's esophagus	7.19e-06	8.01e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	6.87e-06	7.66e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	6.81e-06	7.59e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PPARG—Barrett's esophagus	5.71e-06	6.37e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	4.49e-06	5.01e-05	CbGpPWpGaD
